Deregulation of MCM2–7 can be potential biomarkers in meningioma tumor tissues[37].Consistent with the previous findings, our present work observed deregulations of MCM1–10 genes in LUAD cancer tissues which can be serve as potential diagnostic biomarkers. The gene discussed is MCM2; the disease is meningioma.